Kailera Therapeutics · 2 days ago
Senior Manager, Patient Safety and Pharmacovigilance Quality
Kailera is committed to developing therapies that transform lives and improve health. The Senior Manager, Patient Safety and Pharmacovigilance Quality will maintain and enhance the pharmacovigilance quality system, ensuring compliance with regulatory requirements and leading continuous improvement initiatives.
BiotechnologyPharmaceuticalTherapeutics
Responsibilities
Monitor global regulatory requirements, procedures, and guidance (e.g., ICH, FDA, EMA, MHRA, TGA, and ICH-GCP/ICH-E2E guidelines, etc.) and assess impact on existing procedures and recommending updates
Working knowledge of global PV regulations, including FDA and ICH guidelines
Develop and maintain quality metrics for PSPV operations (e.g., SAE case reconciliation, inline and retrospective ICSR review, etc.)
Identify process gaps and develop stage-appropriate solutions within PSPV and the safety vendor
Support the development and maintenance of PSPV departmental Key Performance Indicators (KPI), Key Quality Indicators (KQIs), and monthly compliance metrics
Develop and implement processes for the management of all PSPV procedures and controlled documents (e.g., Policies, SOPs, WIs)
Track PV deviations, compliance issues, or other quality events
Contribute to CAPA development, review, monitor, and trend root cause analyses and propose preventive actions
Partner with Quality Assurance and other key stakeholders and provide PSPV input into organizational initiatives (e.g. quality monitoring, system implementations/improvements, process changes, inspection readiness)
Contribute to the maintenance of PSPV Pharmacovigilance Agreements
Support PSPV document review activities (e.g., signal detection, DSUR, risk management plans, literature review, etc.)
Maintain inspection readiness for PSPV activities, including support for audits and health authority inspections
Support TMF filing activities
Track PSPV commitments from internal audits, regulatory inspection findings, safety vendor non-compliance, and CAPAs
Provide PSPV compliance training to internal and external teams
Promote a culture of compliance, operational excellence, and continuous improvement within the PSPV team and cross-functionally
Drive and/or support initiatives to standardize procedures, improve efficiency, and manage change within PSPV operations
Participate in PSPV and cross-functional team meetings and in vendor governance activities (e.g., KPI review, quality metrics, deviation tracking, etc.)
Other activities/responsibilities as required
Qualification
Required
Minimum of 8+ years of experience in Drug Safety/Pharmacovigilance (specifically, PV quality and compliance, and/or operations) within the pharmaceutical or biotechnology industry
Knowledge of global safety and PV regulations, guidelines, and industry standards (FDA, EMA, ICH, GVP, GxP)
Demonstrated experience in audits/inspections, quality investigations, or CAPA management
Proven ability to identify issues, analyze root causes, propose, and implement effective solutions
Strong organizational, time management, and project prioritization skills, including excellent verbal and written communication and interpersonal skills, and proficient computer skills, including Microsoft Word and Excel
Demonstrated ability to work collaboratively in a fast-paced, cross-functional, and matrixed environment, and adaptable to changing priorities
Must be able and willing to travel on occasion
Bachelor's degree in Life Sciences (or equivalent experience) or a related field required. (BS, RN, preferred)
Preferred
Prior PV quality and compliance and vendor management experience preferred
Benefits
Comprehensive health coverage
Flexible time off
Paid holidays
Year-end shutdown
Monthly wellness stipend
Generous 401(k) match
Tuition reimbursement
Commuter benefits
Disability and life insurance
Annual bonus opportunities
Equity grants
Company
Kailera Therapeutics
Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.
Funding
Current Stage
Growth StageTotal Funding
$1BKey Investors
Bain Capital Private Equity
2025-10-14Series B· $600M
2024-10-01Series A· $400M
Recent News
2026-01-05
2025-12-24
2025-12-17
Company data provided by crunchbase